Measles Immune Suppression: Functional Impairment or Numbers Game?

PLoS Pathogens

Volumn 10, Issue 12, 2014, Pages

  de Vries, Rory D ^a   de Swart, Rik L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL FUNCTION; DENDRITIC CELL; FUNCTIONAL DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MEASLES; MORBILLIVIRUS INFECTION; NONHUMAN; RESPIRATORY EPITHELIUM; T LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE; MEASLES VIRUS; OPPORTUNISTIC INFECTIONS; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

CELL PROLIFERATION; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTES; MEASLES; MEASLES VIRUS; OPPORTUNISTIC INFECTIONS; RISK FACTORS;

EID: 84919681078     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004482     Document Type: Article

References (70)

1. Schneider-Schaulies S, Schneider-Schaulies J, (2009) Measles virus-induced immunosuppression. Curr Top Microbiol Immunol 330: 243–269.
2. Hahm B, (2009) Hostile communication of measles virus with host innate immunity and dendritic cells. Curr Top Microbiol Immunol 330: 271–287.
3. Griffin DE, (2010) Measles virus-induced suppression of immune responses. Immunol Rev 236: 176–189.
4. Beckford AP, Kaschula RO, Stephen C, (1985) Factors associated with fatal cases of measles. A retrospective autopsy study. S Afr Med J 68: 858–863.
5. Akramuzzaman SM, Cutts FT, Wheeler JG, Hossain MJ, (2000) Increased childhood morbidity after measles is short-term in urban Bangladesh. Am J Epidemiol 151: 723–735.
6. Van den Hof S, Conyn-van Spaendonck MAE, van Steenbergen JE, (2002) Measles epidemic in the Netherlands, 1999–2000. J Infect Dis 186: 1483–1486.
7. Shanks GD, Lee SE, Howard A, Brundage JF, (2011) Extreme mortality after first introduction of measles virus to the polynesian island of Rotuma, 1911. Am J Epidemiol 173: 1211–1222.
8. Griffin DE, Ward BJ, Jauregui E, Johnson RT, Vaisberg A, (1989) Immune activation in measles. N Engl J Med 320: 1667–1672.
9. Von Pirquet CE, (1908) Das Verhalten der kutanen Tuberkulin-reaktion während der Masern. Dtsch Med Wochenschr 34: 1297–1300.
10. McChesney MB, Miller CJ, Rota PA, Zhu Y, Antipa L, et al. (1997) Experimental measles I. Pathogenesis in the normal and the immunized host. Virology 233: 74–84.
11. De Swart RL, Ludlow M, De Witte L, Yanagi Y, Van Amerongen G, et al. (2007) Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3: e178.
12. Tatsuo H, Ono N, Tanaka K, Yanagi Y, (2000) SLAM (CDw150) is a cellular receptor for measles virus. Nature 406: 893–897.
13. De Vries RD, McQuaid S, Van Amerongen G, Yüksel S, Verburgh RJ, et al. (2012) Measles immune suppression: lessons from the macaque model. PLoS Pathog 8: e1002885.
14. Condack C, Grivel JC, Devaux P, Margolis L, Cattaneo R, (2007) Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis 196: 541–549.
15. Grosjean I, Caux C, Bella C, Berger I, Wild F, et al. (1997) Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J Exp Med 186: 801–812.
16. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan MC, Liu YJ, et al. (1997) Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 186: 813–823.
17. Schnorr JJ, Xanthakos S, Keikavoussi P, Kampgen E, Ter Meulen V, et al. (1997) Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immmunosuppression. Proc Natl Acad Sci U S A 94: 5326–5331.
18. Ferreira CS, Frenzke M, Leonard VH, Welstead GG, Richardson CD, et al. (2010) Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150). J Virol 84: 3033–3042.
19. Lemon K, De Vries RD, Mesman AW, McQuaid S, Van Amerongen G, et al. (2011) Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog 7: e1001263.
20. Moss WJ, Griffin DE, (2012) Measles. Lancet 379: 153–164.
21. Van Binnendijk RS, Poelen MCM, Kuijpers KC, Osterhaus ADME, UytdeHaag FGCM, (1990) The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. J Immunol 144: 2394–2399.
22. Permar SR, Klumpp SA, Mansfield KG, Kim WK, Gorgone DA, et al. (2003) Role of CD8+ lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J Virol 77: 4396–4400.
23. De Vries RD, Yüksel S, Osterhaus ADME, De Swart RL, (2010) Specific CD8+ T-lymphocytes control dissemination of measles virus. Eur J Immunol 40: 388–395.
24. Mongkolsapaya J, Jaye A, Callan MFC, Magnusen AF, McMichael AJ, et al. (1999) Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection. J Virol 73: 67–71.
25. Ryon JJ, Moss WJ, Monze M, Griffin DE, (2002) Functional and phenotypic changes in circulating lymphocytes from hospitalized Zambian children with measles. Clin Diagn Lab Immunol 9: 994–1003.
26. Finkeldey W, (1931) Über Riesenzellbefunde in den Gaumenmandeln, zugleich ein Beitrag zur Histopathologie der Mandelveränderungen im Maserninkubationsstadium. Virchows Arch 281: 323–329.
27. Warthin AS, (1931) Occurrence of numerous large giant cells in the tonsils and pharyngeal mucosa in the prodromal stage of measles. Arch Pathol 11: 864–874.
28. Lisse I, Samb B, Whittle H, Jensen H, Soumare M, et al. (1998) Acute and long-term changes in T-lymphocyte subsets in response to clinical and subclinical measles. A community study from rural Senegal. Scand J Infect Dis 30: 17–21.
29. Noyce RS, Bondre DG, Ha MN, Lin LT, Sisson G, et al. (2011) Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog 7: e1002240.
30. Mühlebach MD, Mateo M, Sinn PL, Prufer S, Uhlig KM, et al. (2011) Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 480: 530–533.
31. Pratakpiriya W, Seki F, Otsuki N, Sakai K, Fukuhara H, et al. (2012) Nectin4 is an epithelial cell receptor for canine distemper virus and involved in the neurovirulence. J Virol 86: 10207–10210.
32. Racaniello V, (2011) An exit strategy for measles virus. Science 334: 1650–1651.
33. Ludlow M, Lemon K, De Vries RD, McQuaid S, Millar E, et al. (2013) Measles virus infection of epithelial cells in the macaque upper respiratory tract is mediated by sub-epithelial immune cells. J Virol 87: 4033–4042.
34. Ludlow M, De Vries RD, Lemon K, McQuaid S, Millar E, et al. (2013) Infection of lymphoid tissues in the macaque upper respiratory tract contributes to the emergence of transmissible measles virus. J Gen Virol 94: 1933–1944.
35. Vareille M, Kieninger E, Edwards MR, Regamey N, (2011) The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev 24: 210–229.
36. Beineke A, Puff C, Seehusen F, Baumgärtner W, (2009) Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet Immunol Immunopathol 127: 1–18.
37. Nguyen DT, Ludlow M, Van Amerongen G, De Vries RD, Yüksel S, et al. (2012) Evaluation of synthetic infection-enhancing lipopeptides as adjuvants for a live-attenuated canine distemper virus vaccine administered intra-nasally to ferrets. Vaccine 30: 5073–5080.
38. McCullough B, Krakowka S, Koestner A, (1974) Experimental canine distemper virus-induced lymphoid depletion. Am J Pathol 74: 155–170.
39. Von Messling V, Springfeld C, Devaux P, Cattaneo R, (2003) A ferret model of canine distemper virus virulence and immunosuppression. J Virol 77: 12579–12591.
40. Von Messling V, Milosevic D, Cattaneo R, (2004) Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci U S A 101: 14216–14421.
41. Hirsch RL, Griffin DE, Johnson RT, Cooper SJ, Lindo de Soriano I, et al. (1984) Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol 31: 1–12.
42. Ward BJ, Johnson RT, Vaisberg A, Jauregui E, Griffin DE, (1991) Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin Immunol Immunopathol 61: 236–248.
43. Griffin DE, Ward BJ, (1993) Differential CD4 T cell activation in measles. J Infect Dis 168: 275–281.
44. Schlender J, Schnorr JJ, Spielhofer P, Cathomen T, Cattaneo R, et al. (1996) Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc Natl Acad Sci U S A 93: 13194–13199.
45. Schnorr JJ, Seufert M, Schlender J, Borst J, Johnston ICD, et al. (1997) Cell cycle arrest rather than apoptosis is associated with measles virus contact-mediated immunosuppression in vitro. J Gen Virol 78: 3217–3226.
46. Moussallem TM, Guedes F, Fernandes ER, Pagliari C, Lancellotti CLP, et al. (2007) Lung involvement in childhood measles: severe immune dysfunction revealed by quantitative immunohistochemistry. Hum Pathol 38: 1239–1247.
47. Polack FP, Hoffman SJ, Moss WJ, Griffin DE, (2002) Altered synthesis of interleukin-12 and type 1 and type 2 cytokines in rhesus macaques during measles and atypical measles. J Infect Dis 185: 13–19.
48. Atabani SF, Byrnes AA, Jaye A, Kidd IM, Magnusen AF, et al. (2001) Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis 184: 1–9.
49. Hoffman SJ, Polack FP, Hauer DA, Griffin DE, (2003) Measles virus infection of rhesus macaques affects neutrophil expression of IL-12 and IL-10. Viral Immunol 16: 369–379.
50. Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, et al. (1996) Mechanism of suppression of cell-mediated immunity by measles virus. Science 273: 228–231.
51. Steineur MP, Grosjean I, Bella C, Kaiserlian D, (1998) Langerhans cells are susceptible to measles virus infection and actively suppress T cell proliferation. Eur J Dermatol 8: 413–420.
52. Niewiesk S, Eisenhuth I, Fooks A, Clegg JC, Schnorr JJ, et al. (1997) Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J Virol 71: 7214–7219.
53. Avota E, Avots A, Niewiesk S, Kane LP, Bommhardt U, et al. (2001) Disruption of Akt kinase activation is important for immunosuppression induced by measles virus. Nat Med 7: 725–731.
54. Marie JC, Saltel F, Escola JM, Jurdic P, Wild TF, et al. (2004) Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression. J Virol 78: 11952–11961.
55. Kerdiles YM, Cherif B, Marie JC, Tremillon N, Blanquier B, et al. (2006) Immunomodulatory properties of morbillivirus nucleoproteins. Viral Immunol 19: 324–334.
56. Kerdiles YM, Sellin CI, Druelle J, Horvat B, (2006) Immunosuppression caused by measles virus: role of viral proteins. Rev Med Virol 16: 49–63.
57. Gassert E, Avota E, Harms H, Krohne G, Gulbins E, et al. (2009) Induction of membrane ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganization in viral immunosuppression. PLoS Pathog 5: e1000623.
58. Avota E, Schneider-Schaulies S, (2014) The role of sphingomyelin breakdown in measles virus immunmodulation. Cell Physiol Biochem 34: 20–26.
59. Manchester M, Smith KA, Eto DS, Perkin HB, Torbett BE, (2002) Targeting and hematopoietic suppression of human CD34+ cells by measles virus. J Virol 76: 6636–6642.
60. Boussaad I, Varagnolo L, Hornich V, Rieger L, Krockenberger M, et al. (2011) Wild-type measles virus interferes with short-term engraftment of human CD34+ hematopoietic progenitor cells. J Virol 85: 7710–7718.
61. Addae MM, Komada Y, Taniguchi K, Kamiya T, Osei-Kwasi M, et al. (1998) Surface marker patterns of T cells and expression of interleukin-2 receptor in measles infection. Acta Paediatr Jpn 40: 7–13.
62. Sullivan JL, Barry DW, Lucas SJ, Albrecht P, (1975) Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. J Exp Med 142: 773–784.
63. Huddlestone JR, Lampert PW, Oldstone MBA, (1980) Virus-lymphocyte interactions: infection of Tg and Tm subsets by measles virus. Clin Immunol Immunopathol 15: 502–509.
64. Ito M, Watanabe M, Ihara T, Kamiya H, Sakurai M, (1997) Measles virus induces apoptotic cell death in lymphocytes activated with phorbol 12-myristate 13-acetate (PMA) plus calcium ionophore. Clin Exp Immunol 108: 266–271.
65. Okada H, Kobune F, Sato TA, Kohama T, Takeuchi Y, et al. (2000) Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch Virol 145: 905–920.
66. Pignata C, Fiore M, de Filippo S, Cavalcanti M, Gaetaniello L, et al. (1998) Apoptosis as a mechanism of peripheral blood mononuclear cell death after measles and varicella-zoster virus infections in children. Pediatr Res 43: 77–83.
67. Vuorinen T, Peri P, Vainionpää R, (2003) Measles virus induces apoptosis in uninfected bystander T cells and leads to granzyme B and caspase activation in peripheral blood mononuclear cell cultures. Eur J Clin Invest 33: 434–442.
68. Servet-Delprat C, Vidalain PO, Azocar O, Le Deist F, Fischer A, et al. (2000) Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus. J Virol 74: 4387–4393.
69. Servet-Delprat C, Vidalain PO, Bausinger H, Manie S, Le Deist F, et al. (2000) Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J Immunol 164: 1753–1760.
70. Vidalain PO, Azocar O, Lamouille B, Astier A, Rabourdin-Combe C, et al. (2000) Measles virus induces functional TRAIL production by human dendritic cells. J Virol 74: 556–559.